Investigational drug · Phase 3
matched to SUZ
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Diabetic Peripheral Neuropathic Pain.
Phase 3Last checked: Nov 20, 2026Latest source record: Oct 15, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
2
2 still active
All registered trials
7
Any phase or sponsor naming "matched to SUZ"
First trial start
2024
Oct 1, 2024
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "matched to SUZ", any sponsor or status.
Conditions studied
As listed on its trial records.
- Diabetic Peripheral Neuropathic Pain
Approved drugs for the same conditions: Neuropathic pain · Cardiovascular and metabolic · Neurology · Pain and anesthesia
Largest trials
Live from ClinicalTrials.gov: studies naming "matched to SUZ" as an intervention, largest first.
- Evaluation of Efficacy and Safety of Suzetrigine for Acute Pain After an AbdominoplastyPivotal-lookingCompleted
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
NCT05558410 · 1,118 participants · Start Oct 10, 2022 · Primary completion Aug 25, 2023
Drug: Suzetrigine (SUZ); HB/APAP and 2 more · For: Acute Pain
Sites: Sheffield, Alabama; Phoenix, Arizona; Little Rock, Arkansas · 12 sites in all
- Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral NeuropathyPivotal-lookingRecruiting
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
NCT06628908 · 1,100 participants (planned) · Start Oct 1, 2024 · Primary completion May 31, 2027
Drug: Suzetrigine; Placebo (matched to SUZ) and 2 more · For: Diabetic Peripheral Neuropathic Pain
Sites: Anniston, Alabama; Birmingham, Alabama; Daphne, Alabama · 76 sites in all
- Evaluation of Efficacy and Safety of VX-548 for Acute Pain After a BunionectomyPivotal-lookingCompleted
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
NCT05553366 · 1,075 participants · Start Oct 3, 2022 · Primary completion Dec 15, 2023
Drug: SUZ; HB/APAP and 2 more · For: Acute Pain
Sites: Sheffield, Alabama; Phoenix, Arizona; Little Rock, Arkansas · 21 sites in all
- Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral NeuropathyPivotal-lookingRecruiting
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
NCT07231419 · 734 participants (planned) · Start Nov 21, 2025 · Primary completion Apr 6, 2027
Drug: Suzetrigine; Placebo (matched to SUZ) · For: Diabetic Peripheral Neuropathic Pain
Sites: Birmingham, Alabama; Mobile, Alabama; Glendale, Arizona · 75 sites in all
- Evaluation of Efficacy and Safety of VX-548 for Painful Diabetic Peripheral Neuropathy (DPN)Pivotal-lookingCompleted
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
NCT05660538 · 194 participants · Start Dec 20, 2022 · Primary completion Oct 12, 2023
Drug: Suzetrigine; Pregabalin and 2 more · For: Diabetic Peripheral Neuropathy
Sites: Anniston, Alabama; Birmingham, Alabama; Phoenix, Arizona · 50 sites in all
- Suzetrigine for Acute Pain Control in Patients With Multiple Rib FracturesEnrolling by invitation
University of California, IrvineAcademic, hospital or other
NCT07145346 · 80 participants (planned) · Start Nov 13, 2025 · Primary completion Aug 2027
Drug: Suzetrigine (SUZ); Placebo · For: Rib Fractures
Sites: Orange, California
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
NCT07538570 · 66 participants · Start Apr 24, 2026 · Primary completion Oct 12, 2026
Drug: Suzetrigine; Placebo · For: Pain
Sites: Bellaire, Texas; Houston, Texas
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Diabetic Peripheral Neuropathic Pain
- HL-1186Phase 36 trials
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. · Postoperative Pain, Moderate to Severe Acute Postoperative Pain, Postherpetic Neuralgia ( PHN )
- matched to PregabalinPhase 32 trials
Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain
- LY4065967Phase 23 trials
Eli Lilly · Chronic Pain, Diabetic Peripheral Neuropathic Pain, Osteoarthritis, Knee
- matched to VX-993Phase 22 trials
Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain
- VX-993Phase 22 trials
Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do. More from Vertex Pharmaceuticals.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.